Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)

Механизмы резистентности и современные варианты лечения мультиформной глиобластомы (GBM)
Md Abdus Subhan, Satya Siva Kishan Yalamarty, Nina Filipczak, Farzana Parveen, Vladimir P. Torchilin, Janaína Artem Ataide, Xiang Li, Bharat Ashok Rajmalani
2023-04-01

Blood-brain barrierGlioblastoma multiformeImmune checkpoint inhibitorsTherapy resistanceTumor-treating fields
Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer that is difficult to treat due to its resistance to both radiation and chemotherapy. This resistance is largely due to the unique biology of GBM cells, which can evade the effects of conventional treatments through mechanisms such as increased resistance to cell death and rapid regeneration of cancerous cells. Additionally, the blood-brain barrier makes it difficult for chemotherapy drugs to reach GBM cells, leading to reduced effectiveness. Despite these challenges, there are several treatment options available for GBM. The standard of care for newly diagnosed GBM patients involves surgical resection followed by concurrent chemoradiotherapy and adjuvant chemotherapy. Emerging treatments include immunotherapy, such as checkpoint inhibitors, and targeted therapies, such as bevacizumab, that attempt to attack specific vulnerabilities in GBM cells. Another promising approach is the use of tumor-treating fields, a type of electric field therapy that has been shown to slow the growth of GBM cells. Clinical trials are ongoing to evaluate the safety and efficacy of these and other innovative treatments for GBM, intending to improve with outcomes for patients.
1
Emerging approaches include checkpoint-inhibitor immunotherapy, targeted therapy with bevacizumab, and tumor-treating fields.
2
GBM resists radiation and chemotherapy through enhanced resistance to cell death and rapid regeneration of cancerous cells.
3
Standard treatment for newly diagnosed GBM consists of surgical resection followed by concurrent chemoradiotherapy and adjuvant chemotherapy.
4
The blood-brain barrier limits chemotherapy delivery to GBM cells, reducing treatment effectiveness.
5
Tumor-treating fields have been shown to slow GBM cell growth, while ongoing clinical trials assess innovative treatments’ safety and efficacy.

Glioblastoma multiforme (GBM) cells and tumors

Mechanisms of resistance to radiation and chemotherapy and the effectiveness of current and emerging treatments

Publication Details
Publication Date
2023-04-01
Journal
Publisher
ISSN
Cited by
346
Access Type
Author Information
Authors
Md Abdus Subhan
Satya Siva Kishan Yalamarty
Nina Filipczak
Farzana Parveen
Vladimir P. Torchilin
Janaína Artem Ataide
Xiang Li
Bharat Ashok Rajmalani
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%